112 related articles for article (PubMed ID: 7542976)
1. Nitric oxide is important for mouse beta-cell line killing by peritoneal exudate cells obtained from cyclophosphamide treated non-obese diabetic mice.
Kasuga A; Nakaki T; Takei I; Takayama S; Ozawa Y; Maruyama T; Miyazaki J; Saruta T
Endocr J; 1995 Apr; 42(2):259-63. PubMed ID: 7542976
[TBL] [Abstract][Full Text] [Related]
2. The role of cytotoxic macrophages in non-obese diabetic mice: cytotoxicity against murine mastocytoma and beta-cell lines.
Kasuga A; Maruyama T; Takei I; Shimada A; Kasatani T; Watanabe K; Saruta T; Nakaki T; Habu S; Miyazaki J
Diabetologia; 1993 Dec; 36(12):1252-7. PubMed ID: 8307252
[TBL] [Abstract][Full Text] [Related]
3. An immunohistochemical study of macrophage influx and the co-localization of inducible nitric oxide synthase in the pancreas of non-obese diabetic (NOD) mice during disease acceleration with cyclophosphamide.
Reddy S; Yip S; Karanam M; Poole CA; Ross JM
Histochem J; 1999 May; 31(5):303-14. PubMed ID: 10461865
[TBL] [Abstract][Full Text] [Related]
4. Immunoexpression of interleukin-1beta in pancreatic islets of NOD mice during cyclophosphamide-accelerated diabetes: co-localization in macrophages and endocrine cells and its attenuation with oral nicotinamide.
Reddy S; Young M; Ginn S
Histochem J; 2001 Jun; 33(6):317-27. PubMed ID: 11758808
[TBL] [Abstract][Full Text] [Related]
5. Comparison of mRNA contents of interleukin-1 beta and nitric oxide synthase in pancreatic islets isolated from female and male nonobese diabetic mice.
Welsh M; Welsh N; Bendtzen K; Mares J; Strandell E; Oberg C; Sandler S
Diabetologia; 1995 Feb; 38(2):153-60. PubMed ID: 7536171
[TBL] [Abstract][Full Text] [Related]
6. Suppression of cyclophosphamide induced diabetes development and pancreatic Th1 reactivity in NOD mice treated with the interleukin (IL)-12 antagonist IL-12(p40)2.
Rothe H; O'Hara RM; Martin S; Kolb H
Diabetologia; 1997 Jun; 40(6):641-6. PubMed ID: 9222642
[TBL] [Abstract][Full Text] [Related]
7. Inducible nitric oxide synthase in pancreatic islets of the non-obese diabetic mouse: a light and confocal microscopical study of its ontogeny, co-localization and up-regulation following cytokine administration.
Reddy S; Kaill S; Poole CA; Ross J
Histochem J; 1997 Jan; 29(1):53-64. PubMed ID: 9088945
[TBL] [Abstract][Full Text] [Related]
8. The role of nitric oxide in the pathogenesis of spontaneous murine autoimmune disease: increased nitric oxide production and nitric oxide synthase expression in MRL-lpr/lpr mice, and reduction of spontaneous glomerulonephritis and arthritis by orally administered NG-monomethyl-L-arginine.
Weinberg JB; Granger DL; Pisetsky DS; Seldin MF; Misukonis MA; Mason SN; Pippen AM; Ruiz P; Wood ER; Gilkeson GS
J Exp Med; 1994 Feb; 179(2):651-60. PubMed ID: 7507509
[TBL] [Abstract][Full Text] [Related]
9. Macrophage-generated nitric oxide as cytotoxic factor in destruction of alginate-encapsulated islets. Protection by arginine analogs and/or coencapsulated erythrocytes.
Wiegand F; Kröncke KD; Kolb-Bachofen V
Transplantation; 1993 Nov; 56(5):1206-12. PubMed ID: 8249124
[TBL] [Abstract][Full Text] [Related]
10. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y
Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012
[TBL] [Abstract][Full Text] [Related]
11. Apoptosis and beta-cell destruction in pancreatic islets of NOD mice with spontaneous and cyclophosphamide-accelerated diabetes.
Augstein P; Elefanty AG; Allison J; Harrison LC
Diabetologia; 1998 Nov; 41(11):1381-8. PubMed ID: 9833948
[TBL] [Abstract][Full Text] [Related]
12. The role of nitric oxide as an effector of macrophage-mediated cytotoxicity against Trichomonas vaginalis.
Park GC; Ryu JS; Min DY
Korean J Parasitol; 1997 Sep; 35(3):189-95. PubMed ID: 9335184
[TBL] [Abstract][Full Text] [Related]
13. Suppression of diabetes mellitus in the non-obese diabetic (NOD) mouse by an autoreactive (anti-I-Ag7) islet-derived CD4+ T-cell line.
Chosich N; Harrison LC
Diabetologia; 1993 Aug; 36(8):716-21. PubMed ID: 8405738
[TBL] [Abstract][Full Text] [Related]
14. Nitric oxide mediates IL-1 beta-induced islet dysfunction and destruction: prevention by dexamethasone.
Corbett JA; Wang JL; Misko TP; Zhao W; Hickey WF; McDaniel ML
Autoimmunity; 1993; 15(2):145-53. PubMed ID: 7692996
[TBL] [Abstract][Full Text] [Related]
15. Inhibition of nitric oxide generation affects the induction of diabetes by streptozocin in mice.
Lukic ML; Stosic-Grujicic S; Ostojic N; Chan WL; Liew FY
Biochem Biophys Res Commun; 1991 Aug; 178(3):913-20. PubMed ID: 1831356
[TBL] [Abstract][Full Text] [Related]
16. Evidence that beta cell death in the nonobese diabetic mouse is Fas independent.
Thomas HE; Darwiche R; Corbett JA; Kay TW
J Immunol; 1999 Aug; 163(3):1562-9. PubMed ID: 10415060
[TBL] [Abstract][Full Text] [Related]
17. Fas and Fas ligand immunoexpression in pancreatic islets of NOD mice during spontaneous and cyclophosphamide-accelerated diabetes.
Reddy S; Ross JM
Ann N Y Acad Sci; 2003 Nov; 1005():166-9. PubMed ID: 14679052
[TBL] [Abstract][Full Text] [Related]
18. Role of macrophage-derived nitric oxide in suppression of lymphocyte proliferation during blood-stage malaria.
Ahvazi BC; Jacobs P; Stevenson MM
J Leukoc Biol; 1995 Jul; 58(1):23-31. PubMed ID: 7542305
[TBL] [Abstract][Full Text] [Related]
19. Immunohistochemical study of caspase-3-expressing cells within the pancreas of non-obese diabetic mice during cyclophosphamide-accelerated diabetes.
Reddy S; Bradley J; Ginn S; Pathipati P; Ross JM
Histochem Cell Biol; 2003 Jun; 119(6):451-61. PubMed ID: 12802593
[TBL] [Abstract][Full Text] [Related]
20. A potent immunomodulatory compound, (S,R)-3-Phenyl-4,5-dihydro-5-isoxazole acetic acid, prevents spontaneous and accelerated forms of autoimmune diabetes in NOD mice and inhibits the immunoinflammatory diabetes induced by multiple low doses of streptozotocin in CBA/H mice.
Stosic-Grujicic S; Cvetkovic I; Mangano K; Fresta M; Maksimovic-Ivanic D; Harhaji L; Popadic D; Momcilovic M; Miljkovic D; Kim J; Al-Abed Y; Nicoletti F
J Pharmacol Exp Ther; 2007 Mar; 320(3):1038-49. PubMed ID: 17148780
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
